Utilisation and safety of asenapine in secondary care in the United Kingdom: Results from the observational safety evaluation of asenapine (OBSERVA) study

被引：0
|
作者：
Dhanda, Sandeep [1 ,2 ]
Slade, Jan [1 ]
Osborne, Vicki [1 ]
Wise, Lesley [1 ]
Shakir, Saad [1 ,2 ]
机构：
[1] Drug Safety Res Unit, Southampton, Hants, England
[2] Univ Portsmouth, Portsmouth, Hants, England
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
593
引用
收藏
页码：272 / 273
页数：2
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GO-COLITIS
    Probert, C.
    Gaya, D.
    Hamlin, P. J.
    Irving, P.
    Sebastian, S.
    Gillespie, G.
    Tate, H.
    Wheeler, C.
    GUT, 2017, 66 : A8 - A8
  • [42] Safety of the Hexavalent Vaccine as Used in General Practice: Interim Results from a Prospective Observational Study
    Bulik, N. Beatrix
    Bucsa, C.
    Farcas, A.
    Oniga, O.
    DRUG SAFETY, 2017, 40 (10) : 973 - 974
  • [43] Initial safety results from a multinational, prospective, observational study in advanced melanoma (MEL) (IMAGE)
    Middleton, M.
    Dalle, S.
    Corrie, P.
    Loquai, C.
    Terheyden, P.
    Kaehler, K. C.
    Meiss, F.
    Board, R.
    Arance, A. M.
    Gutzmer, R.
    Tarhini, A.
    Dummer, R.
    Ernst, S.
    Richtig, E.
    Wolter, P.
    Bulger, K.
    Kotapati, S.
    Le, T. K.
    Brokaw, J.
    Abernethy, A. P.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S678 - S679
  • [44] Effectiveness and Safety of Tofacitinib in Canadian Patients with RA: Primary Results from a Multicenter, Observational Study
    Haraoui, Boulos
    Khraishi, Majed
    Choquette, Denis
    Lisnevskaia, Larissa
    Teo, Michelle
    Kinch, Cassandra
    Galos, Corina
    Roy, Patrice
    Gruben, David
    Woolcott, John C.
    Vaillancourt, Julie
    Sampalis, John
    Keystone, Edward
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3484 - 3487
  • [45] Exploring antibiotic safety: A prospective observational study from a tertiary care public sector hospital
    Pavan, Garapati
    Kumar, Manish
    Dhingra, Sameer
    Kumar, Nitesh
    Ravichandiran, V
    Murti, Krishna
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2024, 28
  • [46] Comparative Safety of Empagliflozin in Routine Care Patients: Interim Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Patorno, Elisabetta
    Tesfaye, Helen
    Wexler, Deborah J.
    Glynn, Robert
    Najafzadeh, Mehdi
    Bessette, Lily G.
    Zakoul, Heidi
    Koeneman, Lisette
    Deruaz-Luyet, Anouk
    Schneeweiss, Sebastian
    DIABETES, 2021, 70
  • [47] Effectiveness and safety of empagliflozin in routine care patients: interim results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Patorno, E.
    Pawar, A.
    Bessette, L.
    Franklin, J.
    Najafzadeh, M.
    Wexler, D.
    Deruaz-Luyet, A.
    Brodovicz, K.
    Schneeweiss, S.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S145 - S146
  • [48] Effectiveness and Safety of Empagliflozin in Routine Care Patients: Interim Results from the EMPagliflozin compaRative effectiveness and SafEty (EMPRISE) Study
    Patorno, Elisabetta
    Pawar, Ajinkya
    Bessette, Lily G.
    Franklin, Jessica
    Najafzadeh, Mehdi
    Wexler, Deborah J.
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly
    Schneeweiss, Sebastian
    DIABETES, 2020, 69
  • [49] Characteristics of patients initiated on a reduced dose of rivaroxaban for atrial fibrillation (AF)-Results from the ROSE (Rivaroxaban Observational Safety Evaluation) study
    Davies, Miranda
    Evans, Alison
    Coukan, Flavien
    Wise, Lesley
    Shakir, Saad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 458 - 459
  • [50] Evaluation of the tolerability and safety of oxcarbazepine (Trileptal) in the treatment of epilepsy: Results of a national observational study EPI-TRI
    Mazurkiewicz-Beldzinska, M
    Mankowska, B
    Matheisel, A
    Maczka, M
    Komorniczak, P
    EPILEPSIA, 2005, 46 : 120 - 120
12345